📰 Interim Analysis News
Page 10 - Interim Analysis News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Interim Analysis. Real-time updates on events, politics, business and more.
October 27, 2021
Data to highlight the safety, tolerability and efficacy of LUPKYNIS in patients with lupus nephritis Aurinia Pharmaceuticals Inc. a biopharma company committed to delivering therapeutics that change the course of autoimmune disease, today announced that data from multiple studies of LUPKYNIS™ for the treatment of people with lupus nephritis a serious complication of systemic lupus erythematosus resulting in ...
October 21, 2021
/PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation with a purpose to provide a brighter future for patients, today...
October 11, 2021
/PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation with a purpose to provide a brighter future for patients, today...
October 11, 2021
>> sandra: merck put out a statement. at the interim analysis, it reduced the risk of hospitalization or death by approximately 50%. 7.3% of patients who received this were hospitalized or die day 29 following randomization compared to 14% of placebo treated patients. this is former scott gottlieb how he sees the over all impact of the pill. >> i think they will provide psychological and this drug was probably the best data i have ever seen for orally available drug with respiratory pathogen. th...
October 6, 2021
/PRNewswire/ -- The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and...
October 6, 2021
/PRNewswire/ -- The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and...
October 5, 2021
Read the latest National Institutes of Health headlines, on NewsNow: the one-stop shop for National Institutes of Health news
October 5, 2021
/PRNewswire/ -- The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and...
October 5, 2021
/PRNewswire/ -- The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and...
October 5, 2021
Press release content from PR Newswire. The AP news staff was not involved in its creation.